# Cost-effectiveness of Empagliflozin in Patients With Heart Failure With Preserved Ejection Fraction

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-empagliflozin-in-patients-with-heart-failure-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jimmy Zheng,Justin Parizo,John A. Spertus,Paul A. Heidenreich,Alexander T. Sandhu |
| Citations | 56 |
| DOI | 10.1001/jamainternmed.2022.5010 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/9641590 |
| OpenAlex ID | https://openalex.org/W4308366510 |
| PMID | 36342696 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Justin Parizo](https://scholariq.org/researchers/justin-parizo/)

## Paper journal

- [JAMA Internal Medicine](https://scholariq.org/journals/jama-internal-medicine/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.